Bristol Revises Product Overstocking Impact With $262 Mil. Medicaid Accrual

Bristol-Myers Squibb is increasing its estimate of the impact of wholesaler overstocking by $262 mil. to reflect an adjustment to the amount it has set aside for Medicaid rebate payments